In consequence, methotrexate, as a pteridine derivative, is capable of inhibiting the activation of folic acid to folate by specifically binding to the enzyme dihydrofolate reductase (DHFR), which thereby acts as a quite powerful anti-cancer drug [15]. The gene discussed is DHFR; the disease is cancer.